Telomere Length and the Risk of Alzheimer's Disease: The Rotterdam Study

Lana Fani, Saima Hilal, Sanaz Sedaghat, Linda Broer, Silvan Licher, Pascal P. Arp, Joyce B.J. Van Meurs, M. Kamran Ikram, M. Arfan Ikram

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

There is a wide interest in biomarkers that capture the burden of detrimental factors as these accumulate with the passage of time, i.e., increasing age. Telomere length has received considerable attention as such a marker, because it is easily quantified and it may aid in disentangling the etiology of dementia or serve as predictive marker. We determined the association of telomere length with risk of Alzheimer's disease and all-cause dementia in a population-based setting. Within the Rotterdam Study, we performed quantitative PCR to measure mean leukocyte telomere length in blood. We determined the association of telomere length with risk of Alzheimer's disease until 2016, using Cox regression models. Of 1,961 participants (mean age 71.4±9.3 years, 57.1% women) with a median follow-up of 8.3 years, 237 individuals were diagnosed with Alzheimer's disease. We found a U-shaped association between telomere length and risk of Alzheimer's disease: compared to the middle tertile the adjusted hazard ratio was 1.59 (95% confidence interval (CI), 1.13-2.23) for the lowest tertile and 1.47 (1.03-2.10) for the highest tertile. Results were similarly U-shaped but slightly attenuated for all-cause dementia. In conclusion, shorter and longer telomere length are both associated with an increased risk of Alzheimer's disease in the general population.

Original languageEnglish (US)
Pages (from-to)707-714
Number of pages8
JournalJournal of Alzheimer's Disease
Volume73
Issue number2
DOIs
StatePublished - 2020
Externally publishedYes

Bibliographical note

Funding Information:
This work was supported by the European Union’s Horizon 2020 research and innovation programme [grant number 667375] (“CoSTREAM”); the Erasmus Medical Center and Erasmus University Rotterdam; the Netherlands Organization for Scientific Research (NWO) [grant numbers 948-00-010, 918-46-615]; the Netherlands Organization for Health Research and Development (ZonMw); The Research Institute for Diseases in the Elderly (RIDE); the Ministry of Education, Culture and Science; the Ministry of Health, Welfare and Sports; the European Commission (DG XII); and the Municipality of Rotterdam.

Keywords

  • Alzheimer's disease
  • dementia
  • population-based
  • prospective cohort study
  • telomere

Fingerprint Dive into the research topics of 'Telomere Length and the Risk of Alzheimer's Disease: The Rotterdam Study'. Together they form a unique fingerprint.

Cite this